Hallett David, CSO, reported a transaction classified as withholding at RECURSION PHARMACEUTICALS, INC. involving 26657.000000 shares for an estimated $84236.12. Reported holdings after the transaction were 1043837.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Chief Scientific Officer
Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
0 other filings
0 recent txs